Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

		Phase:		Phase 2

		Treatment ID#:		1544 NCT00039494

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Histologically confirmed diagnosis of 1 of the following: Glioblastoma multiforme (grade 4 astrocytoma) Gliosarcomas Other grade 4 astrocytoma variants (e.g., giant cell) Must be enrolled at least 1 week, but no more than 4 weeks, after prior biopsy or surgery

		Last Updated:		06/26/2006

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Glioblastoma Multiforme Gliosarcoma


		Comments:

		Treatment Type:		Chemotherapy Radiation

		Contact:		Toni Kay Mangskau-MN Clinical Trials Referral Coordinator Mayo Clinic Cancer Center - MN 200 First Street SW Rochester, MN 55905 USA Phone: (507)538-7623 Fax: E-mail: mangskau.toni@mayo.edu Website: www.mayoclinic.org/cancer-treatment/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By